ACG and CAG Clinical Guideline: Management of Dyspepsia (Q39385451)

11 September 2017

1 reference

title

ACG and CAG Clinical Guideline: Management of Dyspepsia (English)

1 reference

11 September 2017

Paul M Moayyedi

1

1 reference

11 September 2017

Brian E Lacy

2

1 reference

11 September 2017

Christopher N Andrews

3

1 reference

11 September 2017

Robert A Enns

4

1 reference

11 September 2017

Colin W Howden

5

1 reference

11 September 2017

Nimish Vakil

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

20 June 2017

1 reference

The American Journal of Gastroenterology

11 September 2017

1 reference

11 September 2017

112

1 reference

11 September 2017

988-1013

1 reference

11 September 2017

7

1 reference

Three centuries of stomach symptoms in Scotland.

11 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Functional dyspepsia: the economic impact to patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

21 January 2018

Gastroduodenal Disorders

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Guidelines for the diagnosis and management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Going from evidence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Esophageal adenocarcinoma incidence: are we reaching the peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Can the clinical history distinguish between organic and functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Quality indicators for colonoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Meta-analysis:Helicobacter pylori‘test and treat’ compared with empirical acid suppression for managing dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori infection in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Helicobacter pylori eradication in functional dyspepsia: HEROES trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Evaluation of duodenal hypersensitivity induced by duodenal acidification using transnasal endoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Therapy: Risks associated with chronic PPI use - signal or noise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

21 January 2018

The risks of PPI therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Review article: current treatment options and management of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Extra-cranial aneurysm of the internal carotid artery treated by proximal ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Teething complications, a persisting misconception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A systematic review of psychological therapies for nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A qualitative study of complementary and alternative medicine use in persons with uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A 32-year-old woman with chronic abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Functional dyspepsia and gastroparesis: one disease or two?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Measurement of gastric accommodation: a reappraisal of conventional and emerging modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Lack of relationship between chronic upper abdominal symptoms and gastric function in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Clinical guideline: management of gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

Cost-effectiveness analysis of two management strategies for dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2017.154

A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.

21 January 2018

1 reference

12 December 2020

Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying

1 reference

12 December 2020

Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms

1 reference

12 December 2020

Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study

1 reference

12 December 2020

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

12 December 2020

Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients

1 reference

12 December 2020

Gastro-oesophageal reflux disease

1 reference

12 December 2020

Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia

1 reference

12 December 2020

Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia

1 reference

12 December 2020

Meta-analysis of traditional Chinese medicine in treating functional dyspepsia of liver-stomach disharmony syndrome

1 reference

12 December 2020

Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia

1 reference

12 December 2020

Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial

1 reference

12 December 2020

Acupuncture for functional dyspepsia

1 reference

12 December 2020

The effectiveness of cognitive behavior stress management on functional dyspepsia symptoms

1 reference

12 December 2020

Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients

1 reference

12 December 2020

STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study

1 reference

12 December 2020

Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.

1 reference

12 December 2020

1 reference

12 December 2020

A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress

1 reference

12 December 2020

Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia

1 reference

12 December 2020

Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials

1 reference

12 December 2020

Helicobacter pylori eradication for the prevention of gastric neoplasia

1 reference

12 December 2020

Helicobacter pylori Eradication for Functional Dyspepsia: What Are We Treating?

1 reference

12 December 2020

Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.

1 reference

12 December 2020

Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial

1 reference

12 December 2020

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group

1 reference

12 December 2020

Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study

1 reference

12 December 2020

Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting

1 reference

12 December 2020

Clinical and economic consequences of dyspepsia in the community

1 reference

12 December 2020

Cost-effectiveness analysis of two management strategies for dyspepsia

1 reference

12 December 2020

Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial

1 reference

12 December 2020

Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia.

1 reference

12 December 2020

Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification

1 reference

12 December 2020

Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care

1 reference

12 December 2020

Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial

1 reference

12 December 2020

Psychotherapy in functional dyspepsia

1 reference

12 December 2020

Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia

1 reference

12 December 2020

Efficacy of cisapride therapy in functional dyspepsia

1 reference

12 December 2020

Flexible Coping Psychotherapy for Functional Dyspeptic Patients: A Randomized, Controlled Trial

1 reference

12 December 2020

Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.

1 reference

12 December 2020

Adverse events of upper GI endoscopy

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2017.154

1 reference

release_evbgr7kgdfdgveyqdqbshsmxry

11 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/evbgr7kgdfdgveyqdqbshsmxry

24 November 2022

mapped directly with Wikidata item

1 reference